pregnan-3,6-diol-20-one: RN given refers to (3alpha,5beta,6alpha)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 101774 |
| CHEMBL ID | 514852 |
| CHEBI ID | 34355 |
| MeSH ID | M0145780 |
| Synonym |
|---|
| pregnan-20-one,6-dihydroxy-, (3.alpha.,5.beta.,6.alpha.)- |
| 570-78-5 |
| wln: l e5 b666tj a1 e1 fv1 lq oq |
| 5.beta.-pregnan-20-one,6.alpha.-dihydroxy- |
| nsc-50920 |
| nsc50920 |
| 3.alpha.,6.alpha.-dihydroxy-5.beta.-pregnan-20-one |
| pregnan-20-one, 3,6-dihydroxy-, (3alpha,5beta,6alpha)- |
| pregnan-20-one, 3,6-dihydroxy-, (3-alpha,5-beta,6-alpha)- |
| pregnan-3,6-diol-20-one |
| einecs 209-333-8 |
| 3-alpha,6-alpha-dihydroxy-5-beta-pregnan-20-one |
| 5beta-pregnan-20-one, 3alpha,6alpha-dihydroxy- |
| 5-beta-pregnan-20-one, 3-alpha,6-alpha-dihydroxy- |
| nsc 50920 |
| 6-alpha-hydroxypregnanolone |
| 6alpha-hydroxypregnanolone |
| 3alpha,6alpha-dihydroxy-5beta-pregnan-20-one |
| chebi:34355 , |
| CHEMBL514852 |
| 617is2u65v , |
| unii-617is2u65v |
| diolone |
| 3,6-dihydroxypregnan-20-one |
| 5-beta-pregnan-3-alpha,6-alpha-diol-20-one |
| pregnan-20-one, 3,6-dihydroxy-, (3.alpha.,5.beta.,6.alpha.)- |
| 6.alpha.-hydroxyeltanolone |
| 6.alpha.-hydroxypregnanolone |
| 5.beta.-pregnan-20-one,3.alpha.,6.alpha.-dihydroxy- |
| 3.alpha.,6.alpha.-dihydroxy-5.beta.-pregnane-20-one |
| 5.beta.-pregnane-3.alpha.,6.alpha.-diol-20-one |
| Q27116012 |
| 5-beta-pregnan-3-alpha, 6-alpha-diol-20-one |
| DTXSID60972491 |
| Class | Description |
|---|---|
| corticosteroid hormone | Any of a class of steroid hormones that are produced in the adrenal cortex. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID358768 | Cytotoxicity against mouse GT1-7 cells at 1 uM | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Jul-17, Volume: 104, Issue:29 | Hot spots in prion protein for pathogenic conversion. |
| AID358767 | Inhibition of scrapie form PrP production in mouse GT1-7 cells infected with human transmissible spongiform encephalopathies agent Fukuoka1 by Western blot | 2007 | Proceedings of the National Academy of Sciences of the United States of America, Jul-17, Volume: 104, Issue:29 | Hot spots in prion protein for pathogenic conversion. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.59) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||